Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

INTRODUCTION: Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown. MATERIALS AND METHODS: The European Respiratory Society (ERS) SHARP Clinical Research Collabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Frix, Anne-Noelle, Heaney, Liam G., Dahlén, Barbro, Mihaltan, Florin, Sergejeva, Svetlana, Popović-Grle, Sanja, Sedlak, Vratislav, Lehtimäki, Lauri, Bourdin, Arnaud, Korn, Stephanie, Zervas, Eleftherios, Csoma, Zsuzsanna, Lúðvíksdóttir, Dora, Butler, Marcus, Canonica, Giorgio Walter, Grisle, Ineta, Bieksiene, Kristina, Ten Brinke, Anneke, Kuna, Piotr, Chaves Loureiro, Claudia, Nenasheva, Natalia M., Lazic, Zorica, Škrgat, Sabina, Ramos-Barbon, David, Leuppi, Joerg, Gemicioglu, Bilun, Bossios, Apostolos, Porsbjerg, Celeste M., Bel, Elisabeth H., Djukanovic, Ratko, Louis, Renaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589318/
https://www.ncbi.nlm.nih.gov/pubmed/36299366
http://dx.doi.org/10.1183/23120541.00273-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589318/
https://www.ncbi.nlm.nih.gov/pubmed/36299366
http://dx.doi.org/10.1183/23120541.00273-2022

Ejemplares similares